Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer.
Iacovelli R, Ciccarese C, Mosillo C, Bimbatti D, Fantinel E, Stefani L, Simbolo M, Romano M, Mazzarotto R, Brunelli M, Bria E, Scarpa A, Lawlor RT, Artibani W, Tortora G.
Iacovelli R, et al. Among authors: mosillo c.
Target Oncol. 2018 Oct;13(5):649-655. doi: 10.1007/s11523-018-0588-8.
Target Oncol. 2018.
PMID: 30167971